"Designing Growth Strategies is in our DNA"

U.S. Antiepileptic Drugs (AED) Market Size, Share & COVID-19 Impact Analysis, By Drug Generation (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI109143

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Epilepsy, 2022
    2. New Product Launches, Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Pipeline Analysis
    5. Impact of Covid-19 on the Market
  5. U.S. Antiepileptic Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Generation
      1. First Generation Drugs
      2. Second Generation Drugs
      3. Third Generation Drugs
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. UCB S.A.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. GSK plc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. H. Lundbeck A/S
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Eisai Co., Ltd.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Sanofi
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Sunovion Pharmaceuticals Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Jazz Pharmaceuticals, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Epilepsy, 2022
    2. New Product Launches, Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Pipeline Analysis
    5. Impact of Covid-19 on the Market
  5. U.S. Antiepileptic Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Generation
      1. First Generation Drugs
      2. Second Generation Drugs
      3. Third Generation Drugs
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. UCB S.A.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. GSK plc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. H. Lundbeck A/S
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Eisai Co., Ltd.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Sanofi
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Sunovion Pharmaceuticals Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Jazz Pharmaceuticals, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Antiepileptic Drugs Market Revenue Breakdown (USD billion, %), By Drug Generation, 2022 & 2030

Figure 2: U.S. Antiepileptic Drugs Market Value Share (%), By Drug Generation, 2022 & 2030

Figure 3: U.S. Antiepileptic Drugs Market Value Share (%), By Distribution Channel, 2022 & 2030

Table 1: U.S. Antiepileptic Drugs Market Revenue (USD billion) Forecast, By Drug Generation, 2019–2030

Table 2: U.S. Antiepileptic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

U.S. Antiepileptic Drugs (AED) Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 60
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports